Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus
Objectives Traditional cardiovascular risk calculators such as the Framingham Risk Score (FRS) have been shown to underestimate risk in patients with SLE. The QRISK3 calculator is unique in including SLE and corticosteroid use as risk factors. This study aims to assess the validity of QRISK3 compare...
Main Authors: | Manpreet Singh, Maureen McMahon, Jennifer Grossman, Lori Sahakian, Bevra Hahn, Lisa Zhu, Sonia Lele |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-07-01
|
Series: | Lupus Science and Medicine |
Online Access: | https://lupus.bmj.com/content/9/1/e000564.full |
Similar Items
-
QRISK validation and evaluation: QRISK may be less useful
by: Su, M, et al.
Published: (2009) -
QRISK validation and evaluation. QRISK may be less useful.
by: Liew, S, et al.
Published: (2009) -
QRISK validation and evaluation Authors' reply
by: Collins, G, et al.
Published: (2009) -
Identification and Contribution of Inflammation-Induced Novel MicroRNA in the Pathogenesis of Systemic Lupus Erythematosus
by: Ram P. Singh, et al.
Published: (2022-04-01) -
Assessment of QRISK3 as a predictor of cardiovascular disease events in type 2 diabetes mellitus
by: Xiaodie Mu, et al.
Published: (2022-11-01)